The essential update on US external manufacturing

Preview text: The essential update on US external manufacturing 96 Tariffs, FDA capacity, reshoring and…

Tuesday, Oct 13, 2026 at 2:00 AM EasternHubSpot

PharmaSourceThe essential update on US external manufacturing

Fit to screenFull size

Using this email in an article? Credit: PharmaSource email via They Sent It, with a link to this page. Full-size image

Subject: The essential update on US external manufacturing
Preview text: The essential update on US external manufacturing 96 Tariffs, FDA capacity, reshoring and…
From: news@pharmasource.global
Brand: PharmaSource
ESP: HubSpot
Sent: Tue Oct 13, 2026, 2:00 AM ET
Size: 73 KB
Images: 9
Links: 37, 2 of them buttons
Subject length: 49 characters

Against PharmaSource's usual

Sent in its busiest hour, 2 AM, which holds 33% of its emails. The subject is 49 characters; its average is 45.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

Other sending headers (names only): X-Csa-Complaints, X-Mailin-Campaign, X-Mailin-Client, X-sib-id

	Nov 2, 2026 9:30 PM	New report: AI + Digital in Contract Manufacturing 2026
	Oct 27, 2026 9:30 PM	State of the Industry: 70% are optimistic, only 2% believe reshoring pledges
	Oct 23, 2026 2:00 AM	6 themes from CDMO Live Americas 2026
	Oct 13, 2026 2:00 AM	The essential update on US external manufacturing (this email)
	May 14, 2026 5:00 AM	Makary resigns. Who's running the FDA now?
	May 4, 2026 5:00 PM	8 challenges defining pharma outsourcing in 2026
	Apr 27, 2026 5:00 PM	AI, vibe coding and pharma manufacturing